Literature DB >> 26101305

Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients.

Bjørn Rishovd Rund1, Helene Eidsmo Barder2, Julie Evensen3, Ulrik Haahr4, Wenche ten Velden Hegelstad5, Inge Joa6, Jan Olav Johannessen6, Johannes Langeveld5, Tor Ketil Larsen7, Ingrid Melle8, Stein Opjordsmoen9, Jan Ivar Røssberg3, Erik Simonsen10, Kjetil Sundet11, Per Vaglum12, Thomas McGlashan13, Svein Friis3.   

Abstract

A substantial proportion of schizophrenia-spectrum patients exhibit a cognitive impairment at illness onset. However, the long-term course of neurocognition and a possible neurotoxic effect of time spent in active psychosis, is a topic of controversy. Furthermore, it is of importance to find out what predicts the long-term course of neurocognition. Duration of untreated psychosis (DUP), accumulated time in psychosis the first year after start of treatment, relapse rates and symptoms are potential predictors of the long-term course. In this study, 261 first-episode psychosis patients were assessed neuropsychologically on one or more occasions. Patients were tested after remission of psychotic symptoms and reassessed 1, 2, 5, and 10 years after inclusion. The neurocognitive battery consisted of California Verbal Learning Test, Wisconsin Card Sorting Test, Controlled Oral Word Association Task, Trail Making A and B, and Finger Tapping. We calculated a composite score by adding the z-scores of 4 tests that were only moderately inter-correlated, not including Finger Tapping. Data were analyzed by a linear mixed model. The composite score was stable over 10 years. No significant relationship between psychosis before (DUP) or after start of treatment and the composite score was found, providing no support for the neurotoxicity hypothesis, and indicating that psychosis before start of treatment has no significant impact on the course and outcome in psychosis. We found no association between symptoms and the neurocognitive trajectory. Stable remission during the first year predicted neurocognitive functioning, suggesting that the early clinical course is a good predictor for the long-term course.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DUP; neurocognition; neurotoxicity; relapse; schizophrenia; symptoms

Mesh:

Year:  2015        PMID: 26101305      PMCID: PMC4681546          DOI: 10.1093/schbul/sbv083

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  68 in total

Review 1.  Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Authors:  Ralitza Gueorguieva; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2004-03

2.  Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.

Authors:  Neeltje E M van Haren; Hilleke E Hulshoff Pol; Hugo G Schnack; Wiepke Cahn; René C W Mandl; D Louis Collins; Alan C Evans; René S Kahn
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

3.  Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery.

Authors:  Aina Holmén; Monica Juuhl-Langseth; Rune Thormodsen; Ingrid Melle; Bjørn Rishovd Rund
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

Review 4.  Are the effects of duration of untreated psychosis socially mediated?

Authors:  Ross M G Norman
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

Review 5.  A review of longitudinal studies of cognitive functions in schizophrenia patients.

Authors:  B R Rund
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

Review 6.  Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations.

Authors:  Maria de Gracia Dominguez; Wolfgang Viechtbauer; Claudia J P Simons; Jim van Os; Lydia Krabbendam
Journal:  Psychol Bull       Date:  2009-01       Impact factor: 17.737

Review 7.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

8.  Cognitive remediation combined with an early intervention service in first episode psychosis.

Authors:  T Østergaard Christensen; L Vesterager; G Krarup; B B Olsen; M Melau; C Gluud; M Nordentoft
Journal:  Acta Psychiatr Scand       Date:  2014-05-16       Impact factor: 6.392

Review 9.  Developmentally moderated expressions of the neuropathology underlying schizophrenia.

Authors:  E F Walker
Journal:  Schizophr Bull       Date:  1994       Impact factor: 9.306

10.  Ten year neurocognitive trajectories in first-episode psychosis.

Authors:  Helene E Barder; Kjetil Sundet; Bjørn R Rund; Julie Evensen; Ulrik Haahr; Wenche Ten Velden Hegelstad; Inge Joa; Jan O Johannessen; Johannes Langeveld; Tor K Larsen; Ingrid Melle; Stein Opjordsmoen; Jan I Røssberg; Erik Simonsen; Per Vaglum; Thomas McGlashan; Svein Friis
Journal:  Front Hum Neurosci       Date:  2013-10-07       Impact factor: 3.169

View more
  29 in total

1.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

2.  Cognition in schizophrenia: a marker of underlying neurodevelopmental problems?

Authors:  Ingrid Melle
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

3.  Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.

Authors:  Mara Balda; Maria Calvó; Eduardo Padilla; Gonzalo Guerrero; Juan Molina; Nestor V Florenzano; Danielle Kamis; Javier I Escobar; C Robert Cloninger; Gabriel de Erausquin
Journal:  Focus (Am Psychiatr Publ)       Date:  2015

4.  Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.

Authors:  Margo W Menkes; Kristan Armstrong; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

5.  Cognitive Impairment in Never-Medicated Individuals on the Schizophrenia Spectrum.

Authors:  Rodolfo Solís-Vivanco; Felipe Rangel-Hassey; Pablo León-Ortiz; Alejandra Mondragón-Maya; Francisco Reyes-Madrigal; Camilo de la Fuente-Sandoval
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

6.  Longitudinal trajectory of early functional recovery in patients with first episode psychosis.

Authors:  Mei-Hua Hall; Kristina M Holton; Dost Öngür; Debra Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2019-02-28       Impact factor: 4.939

7.  Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia.

Authors:  Peter E Clayson; Robert S Kern; Keith H Nuechterlein; Barbara J Knowlton; Carrie E Bearden; Tyrone D Cannon; Alan P Fiske; Livon Ghermezi; Jacqueline N Hayata; Gerhard S Hellemann; William P Horan; Kimmy Kee; Junghee Lee; Kenneth L Subotnik; Catherine A Sugar; Joseph Ventura; Cindy M Yee; Michael F Green
Journal:  Schizophr Res       Date:  2018-08-16       Impact factor: 4.939

8.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

9.  Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing.

Authors:  Amanda McCleery; Junghee Lee; Alan P Fiske; Livon Ghermezi; Jacqueline N Hayata; Gerhard S Hellemann; William P Horan; Kimmy S Kee; Robert S Kern; Barbara J Knowlton; Kenneth L Subotnik; Joseph Ventura; Catherine A Sugar; Keith H Nuechterlein; Michael F Green
Journal:  Schizophr Res       Date:  2016-07-18       Impact factor: 4.939

Review 10.  Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective.

Authors:  Julia M Sheffield; Nicole R Karcher; Deanna M Barch
Journal:  Neuropsychol Rev       Date:  2018-10-20       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.